As of 28 Aug 2026, Evexia Lifecare Ltd share price is ₹1.40. The stock opened at ₹1.40 and had closed at ₹1.34 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹0.47 and a high of ₹2.38. In terms of performance, Evexia Lifecare Ltd share price has decreased by 6.67% over the past six months and has decreased by 38.05% over the last year.
Evexia Lifecare Charts
Evexia Lifecare Ltd Overview
About Evexia Lifecare
Evexia Lifecare established in 1990, has built a strong legacy over the years, evolving into a diversified business entity. The company was listed on the Bombay Stock Exchange (BSE) in 1994, under the stock code 524444, marking a significant milestone in its journey. Initially, Evexia Lifecare ventured into various business sectors, including healthcare and wellness. The company developed and marketed a variety of products aimed at improving health, wellness, and nutrition. Over the years, Evexia expanded its reach and capabilities, gaining a reputation for quality in the health and wellness space. However, since 2020, the company has made a strategic shift in its business focus. Recognizing the growing demand and potential in the pharmaceutical sector, Evexia pivoted its operations toward the pharmaceutical industry. Specifically, the company began focusing on the trading of pharmaceutical chemicals, forging key partnerships with prominent companies in South India.With this move, the company appears to be positioning itself for long-term success in the pharmaceutical trading space while continuing to build on its legacy of adaptability and business growth.
Evexia Lifecare Ltd Historical Performance
Evexia Lifecare Ltd Fundamental Analysis
Evexia Lifecare Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 29.68 | 35.73 | 24.86 | 25.37 | 20.66 |
| EBITDA | 0.67 | 0.88 | 0.67 | 0.55 | 0.92 |
| Net Profit | 0.41 | 0.47 | 0.41 | 0.32 | 0.59 |
| EPS | - | - | - | - | - |
Evexia Lifecare Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 36.64 |
| MACD | -0.06 |
| 20-Day SMA | 1.43 |
Evexia Lifecare Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Evexia Lifecare Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Pidilite Industries LtdPIDILITIND | ₹1,656.00+0.36% | ₹1,46,382.9 | 63.25 | 22.61% |
| SRF LtdSRF | ₹2,605.00+0.85% | ₹75,137.76 | 42.23 | 13.07% |
| Linde India LtdLINDEINDIA | ₹6,549.00-0.75% | ₹56,696.28 | 96.10 | 12.87% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Evexia Lifecare Ltd today is ₹1.40 on NSE and ₹1.40 on BSE.
- The 52-week high of Evexia Lifecare Ltd is ₹2.38, while the 52-week low is ₹0.47.
- The current market capitalisation of Evexia Lifecare Ltd is approximately ₹263 crore.
- The P/E (Price-to-Earnings) ratio of Evexia Lifecare Ltd is 152.00. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Evexia Lifecare Ltd is 0.53. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Evexia Lifecare Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Evexia Lifecare Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Evexia Lifecare Ltd has delivered a return of approximately -17.65%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Evexia Lifecare Ltd comprises different categories of shareholders. As of Mar 2026, the shareholding is approximately 3.36% promoters, 0.10% FIIs, 0.10% DIIs, and 40.81% public shareholders.
